| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Chief Executive Officer
1 company
Dube Eric M serves as a Chief Executive Officer at TVTX. Across recent SEC filings that breaks down to 0 buys and 47 sells. Those positions are worth an estimated $28.4M at current prices.
Historically, Dube Eric M's trades have earned a middling insider score of 56/100 across 23 rated trades. Over a 12-month horizon, 47.4% of those trades were profitable, with an average 12-month return of -17.8%.
The biggest single holding is TVTX (~$28.4M) as Chief Executive Officer. The recent filings there lean toward selling, a net 946,846 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 400,000 | $63.48 | $25,390,729.21 | -48.0% | - | - | |
| Apr 15, 2026 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell | 64,000 | $41.09 | $2,629,975.10 | -12.9% | +39.3% | - | |
| Feb 3, 2026 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell | 100,087 | $32.28 | $3,230,315.62 | -18.8% | +34.3% | - | |
| Oct 29, 2025 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 120,000 | $30.32 | $3,638,432.15 | -22.3% | +0.2% | - | |
| May 5, 2025 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 18,924 | $21.05 | $398,350.20 | -4.3% | -25.5% | +109.2% | |
| Feb 11, 2025 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell | 11,375 | $24.04 | $273,455.00 | -2.6% | -9.3% | +27.2% | |
| Feb 3, 2025 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell | 50,691 | $20.21 | $1,024,343.45 | -10.5% | +5.9% | +62.4% | |
| Jan 22, 2025 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell | 10,736 | $19.46 | $208,922.56 | -3.0% | -18.4% | +52.8% | |
| Sep 9, 2024 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell | 21,125 | $11.52 | $243,360.00 | -5.5% | +46.0% | +68.3% | |
| Feb 1, 2024 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell | 19,122 | $8.70 | $166,435.06 | -5.2% | -30.2% | +137.9% |